| |
| |
|
| Insider
Information: |
Epstein David R |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
5,146,952 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$303,682 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
5,146,952 |
|
|
| Total
Value |
$303,682 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
0
|
|
Stock
price went up :
|
5
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.5
|
0.0
|
| Percentage
Gain/Loss : |
 59.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
International Flavors & Fragranc... |
IFF |
|
|
0 |
|
0 |
Premium* |
|
|
Rubius Therapeutics, Inc. |
RUBY |
Director |
2022-04-21 |
4,720,012 |
|
0 |
Premium* |
|
|
Axcella Health Inc. |
AXLA |
Director |
2022-05-19 |
209,756 |
2019-06-26 |
0 |
Premium* |
|
|
Evelo Biosciences Inc |
EVLO |
Director |
2022-06-30 |
93,932 |
2020-08-28 |
0 |
Premium* |
|
|
Senti Biosciences, Inc |
SNTI |
Director |
2022-06-08 |
123,252 |
2022-06-08 |
0 |
Premium* |
|
|
Seagen Inc |
SGEN |
|
2023-12-14 |
0 |
2022-11-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EVLO |
Evelo Biosciences Inc |
Director |
– • – |
2022-05-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,926 |
66,957 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2020-02-28 |
4 |
B |
$3.75 |
$7,519 |
D/D |
2,005 |
68,103 |
2.39 |
- |
|
| EVLO |
Evelo Biosciences Inc |
Director |
– • – |
2022-05-27 |
4 |
B |
$1.46 |
$25,000 |
D/D |
17,123 |
84,080 |
2.39 |
% |
|
| EVLO |
Evelo Biosciences Inc |
Director |
– • – |
2022-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,925 |
89,005 |
0 |
- |
|
| EVLO |
Evelo Biosciences Inc |
Director |
– • – |
2022-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,927 |
93,932 |
0 |
- |
|
| SGEN |
Seagen Inc |
Chief Executive Officer |
• • – |
2022-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
107,389 |
107,389 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2020-05-18 |
4 |
B |
$4.75 |
$237,500 |
D/D |
50,000 |
118,103 |
2.39 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2021-04-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,535 |
119,638 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2021-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,534 |
121,172 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2021-06-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,535 |
122,707 |
0 |
- |
|
| SNTI |
Senti Biosciences, Inc |
Director |
– • – |
2022-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
112,519 |
123,252 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2021-08-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,534 |
125,776 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2021-09-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,535 |
127,311 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2021-10-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,535 |
128,846 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2021-11-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,534 |
130,380 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2021-12-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,535 |
131,915 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2022-01-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,535 |
133,450 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,534 |
134,984 |
0 |
- |
|
| SGEN |
Seagen Inc |
CEO |
• • – |
2023-11-10 |
4 |
AS |
$213.01 |
$2,262,166 |
D/D |
(10,620) |
136,598 |
0 |
% |
|
| SGEN |
Seagen Inc |
Chief Executive Officer |
• • – |
2023-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
39,650 |
147,218 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2022-03-16 |
4 |
B |
$1.91 |
$50,000 |
D/D |
26,178 |
161,162 |
2.39 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2022-03-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,535 |
162,697 |
0 |
- |
|
| AXLA |
Axcella Health Inc. |
Director |
– • – |
2022-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
47,059 |
209,756 |
0 |
- |
|
| RUBY |
Rubius Therapeutics, Inc. |
Director |
– • – |
2021-02-11 |
4 |
AS |
$14.93 |
$398,560 |
D/D |
(26,704) |
4,690,012 |
0 |
% |
|
| RUBY |
Rubius Therapeutics, Inc. |
Director |
– • – |
2021-02-10 |
4 |
AS |
$14.79 |
$109,525 |
D/D |
(7,404) |
4,716,716 |
0 |
% |
|
55 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
